Exchange: NASDAQ·Updated 07:52 AM EDT
NNNN logo

NNNN Anbio Biotechnology

$3.50
$0.23
(7.03%)
Pre-Market
Prev Close $3.27
Mkt Cap$450.38M
Vol347.00

About NNNN

Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products. The company was founded on July 27, 2021 and is headquartered in Frankfurt, Germany.
39

Bearish Sentiment

How do you feel about NNNN?

Advertisement|Remove ads.